Unrelated Umbilical Cord Blood Transplantation Using a TBI/FLAG Conditioning Regimen for Adults with Hematologic Malignancies

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 8, 2008, Pages 896-903

  Okada, Masaya ^a   Fujimori, Yoshihiro ^a   Misawa, Mahito ^a   Kai, Shunro ^a   Nakajima, Toshiyuki ^a   Okikawa, Yoshiko ^a   Satake, Atsushi ^a   Itoi, Hisayuki ^a   Takatsuka, Hiroyuki ^a   Itsukuma, Takeyoshi ^a   Nishioka, Keisuke ^a   Tamaki, Hiroya ^a   Ikegame, Kazuhiro ^a   Hara, Hiroshi ^a,b   Ogawa, Hiroyasu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Uegahara Hospital   (Japan)

Author keywords

Adult; Conditioning regimen; Cord blood transplantation (CBT); FLAG; Total body irradiation (TBI)

Indexed keywords

ACICLOVIR; CIPROFLOXACIN; CYCLOSPORIN A; CYTARABINE; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; METHYLPREDNISOLONE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLADDER DISEASE; CARDIOTOXICITY; CELL NUCLEUS; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG TOLERABILITY; DYSPNEA; ECG ABNORMALITY; ENCEPHALITIS; ENGRAFTMENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GRAFT INFECTION; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATURIA; HERPES SIMPLEX; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; LEUKEMIA; LEUKEMIA RELAPSE; LIVER TOXICITY; LUNG TOXICITY; MALE; MONOTHERAPY; MYELODYSPLASTIC SYNDROME; NEPHROTOXICITY; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PNEUMONIA; REFRACTORY ANEMIA; SEPSIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STOMATITIS; SURVIVAL RATE; T CELL LEUKEMIA; THROMBOCYTE COUNT; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CORD BLOOD STEM CELL TRANSPLANTATION; CYTARABINE; FEASIBILITY STUDIES; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HUMANS; KINETICS; MALE; MIDDLE AGED; RISK ASSESSMENT; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 47249093298     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.05.020     Document Type: Article

References (35)

1. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 (1997) 373-381
2. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
3. Koh L.P., and Chao N.J. Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 10 (2004) 1-22
4. Petropoulos D., and Chan K.W. Umbilical cord blood transplantation. Curr Oncol Rep 7 (2005) 406-409
5. Thomas E.D., Buckner C.D., Banaji M., et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49 (1977) 511-533
6. Savarese D.M., Hsieh C., and Stewart F.M. Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors. J Clin Oncol 15 (1997) 2981-2995
7. Estey E., Plunkett W., Gandhi V., et al. Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia. Leuk Lymphoma 9 (1993) 343-350
8. Estey E., Thall P., Andreeff M., et al. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J Clin Oncol 12 (1994) 671-678
9. Visani G., Tosi P., Zinzani P.L., et al. FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects. Eur J Haematol 56 (1996) 308-312
10. Gandhi V., Estey E., Keating M.J., and Plunkett W. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J Clin Oncol 11 (1993) 116-124
11. Ohno R., Tomonaga M., Kobayashi T., et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323 (1990) 871-877
12. Tafuri A., and Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 4 (1990) 826-834
13. Slavin S., Nagler A., Naparstek E., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91 (1998) 756-763
14. Pawson R., Potter M.N., Theocharous P., et al. Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant. Br J Haematol 115 (2001) 622-629
15. Gale R.P., Horowitz M.M., Weiner R.S., et al. Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 16 (1995) 203-208
16. Nishihira H., Kato K., Isoyama K., et al. The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis. Br J Haematol 120 (2003) 516-522
17. Terasaki P.I., and McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 204 (1964) 998-1000
18. Olerup O., and Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39 (1992) 225-235
19. Cereb N., Maye P., Lee S., Kong Y., and Yang S.Y. Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles. Tissue Antigens 45 (1995) 1-11
20. Bannai M., Tokunaga K., Lin L., et al. Discrimination of human HLA-DRB1 alleles by PCR-SSCP (single-strand conformation polymorphism) method. Eur J Immunogenet 21 (1994) 1-9
21. Misawa M., Kai S., Okada M., et al. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. Int J Hematol 83 (2006) 74-79
22. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
23. Schichman S.A., Suess P., Vertino A.M., and Gray P.S. Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment. Bone Marrow Transplant 29 (2002) 243-248
24. Bearman S.I., Appelbaum F.R., Buckner C.D., et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6 (1988) 1562-1568
25. Herzig R.H. High-dose ara-C in older adults with acute leukemia. Leukemia 10 Suppl 1 (1996) S10-S11
26. Rohatiner A.Z., Bassan R., Battista R., et al. High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia. Br J Cancer 62 (1990) 454-458
27. Herzig R.H., Coccia P.F., Lazarus H.M., et al. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation. Semin Oncol 12 (1985) 184-186
28. Kumar M., Saleh A., Rao P.V., et al. Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation. Bone Marrow Transplant 19 (1997) 1061-1064
29. Tomonari A., Takahashi S., Ooi J., et al. Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation. Eur J Haematol 77 (2006) 46-50
30. Takahashi S., Iseki T., Ooi J., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 104 (2004) 3813-3820
31. Laughlin M.J., Barker J., Bambach B., et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344 (2001) 1815-1822
32. Sanz G.F., Saavedra S., Planelles D., et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 98 (2001) 2332-2338
33. Rocha V., Labopin M., Sanz G., et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
34. Long G.D., Laughlin M., Madan B., et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 9 (2003) 772-780
35. Kanda Y., Chiba S., Hirai H., et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood 102 (2003) 1541-1547